Niels Clauson-Kaas A/S

NCK provides cutting edge process development and API manufacturing for biotech and pharmaceutical companies who want to take NCEs from discovery to commercialization. NCK has a well-equipped, state of the art synthesis laboratory used for conducting process development and small-scale, non-GMP manufacture. NCK has its own multi-purpose pilot plant facility operated under Good Manufacturing Practice (GMP). NCK is committed to operating in compliance with GMP as defined by the ICH Q7 GMP Guide for APIs, and rules Governing Medicinal Products in the European Union, Vol. Today NCK provides cutting edge process development and API manufacturing (e.g. We prefer to offer all clients a single point of contact. Our lab have just recently been renovated adding to our production. Most of our projects involve either manufacturing of advanced stage intermediates or Active Pharmaceutical Ingredients (APIs) for pre-clinical and/or clinical trials, produced in accordance with cGMP.